FDA.reportPublic FDA data

Application 210134

Type
NDA
Sponsor
ELI LILLY AND CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BAQSIMIGLUCAGONPOWDER;NASAL3MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0002-6145BaqsimiglucagonEli Lilly and CompanyNDACurrent
0002-6145BaqsimiglucagonEli Lilly and CompanyNDACurrent
0002-6145BaqsimiglucagonEli Lilly and CompanyNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81633SUPPL 2025-03-18
81629SUPPL 2025-03-18
65120SUPPL2020-11-02
65066SUPPL2020-10-29
61041ORIG2019-11-25
59443ORIG2019-07-25
59441ORIG2019-07-24
63063ORIG1900-01-01
63062ORIG1900-01-01
63061ORIG1900-01-01
63060ORIG1900-01-01